EPISODE · Jul 7, 2020 · 28 MIN
Diagnosis and Management of Amyloidosis
Although there are only about 4000 new cases of amyloidosis in the US per year, it can cause preserved ejection fraction heart failure, kidney and liver failure, and neuropathy. Amyloidosis is easily diagnosed and treatable, and it should be considered in the differential diagnosis for these diseases. Morie A. Gertz, MD, from the Mayo Clinic in Rochester, Minnesota, talks with JAMA Clinical Reviews about amyloidosis. Related: Systemic Amyloidosis Recognition, Prognosis, and Therapy
Embed this episode
NOW PLAYING
Diagnosis and Management of Amyloidosis
0:00
28:39
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JAMA Clinical Reviews?
This episode is 28 minutes long.
When was this JAMA Clinical Reviews episode published?
This episode was published on July 7, 2020.
Can I download this JAMA Clinical Reviews episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!